We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA WILL DISCLOSE FIRST GENERIC ANDA FILINGS
FDA WILL DISCLOSE FIRST GENERIC ANDA FILINGS
March 5, 2004
To help generic drug manufacturers determine if they are eligible for marketing exclusivity, the FDA will soon list on its website the date it receives the first substantially complete new drug application challenging a patent on a brand drug.